EU regulatory authorities granted conditional approval to Regeneron’s bispecific antibody odronextamab for two forms of lymphoma.
It’s Regeneron’s first bispecific antibody approval in the world …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
For patients with peripheral artery disease (PAD) and chronic limb-threatening ischemia, drug-eluting stents and drug-coated balloons did not improve amputation-free survival compared with balloon angioplasty
Overly broad definitions, a lack of appropriate, or any, comparison groups, among other things, in studies looking at the incidence, prevalence, and control of the
The preferences of medical students in selecting health messengers for acquiring health-related information.